151 related articles for article (PubMed ID: 36897756)
1. Hemoglobin decline as a signal for hyperprolactinemia onset prior to prolactinoma diagnosis in hypogonadal men.
Rudman Y; Duskin-Bitan H; Richter I; Tsvetov G; Masri-Iraqi H; Akirov A; Shimon I
Andrology; 2023 Oct; 11(7):1398-1407. PubMed ID: 36897756
[TBL] [Abstract][Full Text] [Related]
2. [Hyperprolactinemia unrelated to prolactinoma].
Krysiak R; Okopień B
Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemia and prolactinoma.
Romijn JA
Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
Balabolkin MI; Gerasimov GA; Liubimov AV
Akush Ginekol (Mosk); 1990 Feb; (2):54-7. PubMed ID: 2339765
[TBL] [Abstract][Full Text] [Related]
5. [Prolactinomas and bone mineral density in men].
Naliato EC; Farias ML; Violante AH
Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):183-95. PubMed ID: 16184246
[TBL] [Abstract][Full Text] [Related]
6. The factors associated with the persistence of hypogonadism in male patients with prolactinoma.
Piskinpasa H; Turgut S
Neuro Endocrinol Lett; 2022 Sep; 43(3):154-160. PubMed ID: 36179726
[TBL] [Abstract][Full Text] [Related]
7. Mass screening for hyperprolactinemia and prolactinoma in men.
Miyake A; Ikegami M; Chen CF; Arita N; Aono T; Tanizawa O; Yoshikawa T
J Endocrinol Invest; 1988 May; 11(5):383-4. PubMed ID: 3183301
[TBL] [Abstract][Full Text] [Related]
8. Prolactinomas.
Glezer A; Bronstein MD
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years.
Shimon I; Hirsch D; Tsvetov G; Robenshtok E; Akirov A; Fraenkel M; Eizenberg Y; Herzberg D; Barzilay-Yoseph L; Livner A; Friedrich I; Manisterski Y; Ishay A; Yoel U; Masri H
Endocrine; 2019 Sep; 65(3):656-661. PubMed ID: 31154607
[TBL] [Abstract][Full Text] [Related]
10. Vertebral fractures in males with prolactinoma.
Mazziotti G; Porcelli T; Mormando M; De Menis E; Bianchi A; Mejia C; Mancini T; De Marinis L; Giustina A
Endocrine; 2011 Jun; 39(3):288-93. PubMed ID: 21479837
[TBL] [Abstract][Full Text] [Related]
11. Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study.
Posawetz AS; Trummer C; Pandis M; Aberer F; Pieber TR; Obermayer-Pietsch B; Pilz S; Theiler-Schwetz V
BMC Endocr Disord; 2021 Apr; 21(1):81. PubMed ID: 33902531
[TBL] [Abstract][Full Text] [Related]
12. GIANT PROLACTINOMA. A CASE REPORT.
Šulavíková Z; Krásnik V
Cesk Slov Oftalmol; 2023; 79(3):143-148. PubMed ID: 37344216
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anaemia associated with prolactin-secreting pituitary tumours in men.
Iglesias P; Castro JC; Díez JJ
Int J Clin Pract; 2011 Jun; 65(6):669-73. PubMed ID: 21564439
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Hyperprolactinemia and Clinically Apparent Prolactinomas in Men Undergoing Fertility Evaluation.
Ambulkar SS; Darves-Bornoz AL; Fantus RJ; Wren J; Bennett NE; Halpern JA; Brannigan RE
Urology; 2022 Jan; 159():114-119. PubMed ID: 33766719
[TBL] [Abstract][Full Text] [Related]
15. Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.
Andereggen L; Frey J; Andres RH; Luedi MM; Widmer HR; Beck J; Mariani L; Christ E
Sci Rep; 2021 Mar; 11(1):5122. PubMed ID: 33664388
[TBL] [Abstract][Full Text] [Related]
16. Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis.
Tsigkaropoulou E; Peppa M; Zompola C; Rizos E; Xelioti I; Chatziioannou S; Filippopoulou A; Lykouras L
Gend Med; 2012 Feb; 9(1):56-60. PubMed ID: 22333523
[TBL] [Abstract][Full Text] [Related]
17. True hyperprolactinemia in men without visible pituitary adenoma.
Shimon I; Rudman Y; Manisterski Y; Gorshtein A; Masri H; Duskin-Bitan H
Endocrine; 2021 Jun; 72(3):809-813. PubMed ID: 33566310
[TBL] [Abstract][Full Text] [Related]
18. [Current diagnosis and treatment of hyperprolactinemia].
Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
[TBL] [Abstract][Full Text] [Related]
19. Male prolactinomas presenting with normal testosterone levels.
Shimon I; Benbassat C
Pituitary; 2014 Jun; 17(3):246-50. PubMed ID: 23756784
[TBL] [Abstract][Full Text] [Related]
20. [Hyperprolactin as cause of hypoactive sexual desire in men].
Baltzar MT; Anholm C; Petersen CD
Ugeskr Laeger; 2012 Jun; 174(25):1745-6. PubMed ID: 22713225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
